Of note is that in CF an intrinsic downregulation of the antioxidant response regulator and NF-κB antagonist Nuclear Factor Erythroid 2-related factor 2 (Nrf2) is described (Moliteo et al., 2022). This evidence concerns the gene NFKB1 and cystic fibrosis.